Dsm IP Assets B.v.

California Molecular Electronics Corporation

James Parakka

Robert S Ward

Keith R McCrea

Yuan Tian

Ananth V Iyer

Xuwei Jiang

Robert R Schumaker

Li Li

Durgaprasad Chalasani

Anfeng Wang

James J Marek, Jr

Amphiphilic biomimetic phosphorylcholine-containing silicone compounds for use in both topical and internal applications as components in biomedical devices. The silicone compounds, which include zwitterionic phosphorylcholine groups, may be polymerizable or non-polymerizable. Specific examples of applications include use as active functional components in ophthalmic lenses, ophthalmic lens care solutions, liquid bandages, wound dressings, and lubricious and anti-thrombogenic coatings.

Phosphorylcholine-based amphiphilic silicones for medical applications

Silicone-containing monomer of formula (I); wherein said silicone-containing monomer comprises a silicone-containing moiety and an oxazolidinone moiety and wherein R is a silicone-containing moiety, and Rmay be an H, wherein A represents the oxazolidinone ring of the oxazolidinone moiety and Ris a divalent Calkylene or Carylalkylene. The monomer is used for the preparation of a composition for use in manufacturing of ophthalmic lenses potentially with anti-infective properties. Also, methods of making the present monomers are described.

Silicone-containing monomer

Methods for preparing functionalized polyvinylpyrrolidones with polymerizable functions. Also, amphipathic polydimethylsiloxane-PVP block copolymers, such as and (meth)acrylated and (meth)acrylamide-functionalized polyvinylpyrrolidone compounds, such as The block copolymers are useful as biomaterial components in biomedical devices. They provide improved wettability, lubricity, and material compatibility to the biomedical device, e.g., ophthalmic lenses.

PDMS-PVP block copolymers

Polymers whose surfaces are modified by endgroups that include amphipathic surface-modifying moieties. An amphipathic endgroup of a polymer molecule is an endgroup that contains at least two moieties of significantly differing composition, such that the amphipathic endgroup spontaneously rearranges its positioning in a polymer body to position the moiety on the surface of the body, depending upon the composition of the medium with which the body is in contact, when that re-positioning causes a reduction in interfacial energy. An example of an amphipathic surface-modifying endgroup is one that has both a hydrophobic moiety and a hydrophilic moiety in a single endgroup. For instance, a hydrophilic poly(ethylene oxide) terminated with a hydrophilic hydroxyl group is not surface active in air when the surface-modifying endgroup is bonded to a more hydrophobic base polymer. If the hydroxyl group on the oligomeric poly(ethylene oxide) is replaced by a hydrophobic methoxy ether terminus, the poly(ethylene oxide) becomes surface active in air, and allows the poly(ethylene oxide) groups to crystallize in the air-facing surface. In this example, immersion in water destroys the crystallinity as the poly(ethylene oxide) sorbs water and the hydrophobic methoxy group retreats below the surface of the polymer. Also disclosed are methods and articles of manufacture that make use of these polymers.

Control of polymer surface molecular architecture via amphipathic endgroups

Optoelectronic materials are provided that are bistable organic tautomeric compositions that intraconvert dithio or diseleno carbamate esters and cyclic 1,3-dithia- or -diselena-2-iminium salts of &#x3c0;-conjugated bis-anthracenyl compounds. Specifically disclosed are compounds having the formula: where X is sulfur or selenium; where the R and Rgroups are alkyl or alkyl that together form a ring of carbon atoms; where Ais the anion of a strong acid; and where the Z element is a chiral ring-completing system of atoms that changes chirality on tautomerization. These molecules are in themselves molecular-sized optoelectronic switching devices.

Growing community of inventors

San Bruno, CA, United States of America

James Parakka